ClinicalTrials.gg
RecruitingNCT04964206Updated Jun 9, 2026

Neuraxial Labor Analgesia and Offspring Neurodevelopment

An observational study in Pregnant Women, Labor Pain and Analgesia, Epidural, sponsored by Dong-Xin Wang. Recruiting at 2 sites in China. Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-06-09.

Sponsored by Dong-Xin Wang · Observational

From the registry’s dates

  • Started Oct 2022; still recruiting 4 years later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
4,645
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

How perinatal factors affect the long-term development of children has always been an issue of much concern. This study is designed to explore the potential impact of maternal neuraxial labor analgesia exposure on offspring neurodevelopment.

Read the detailed description

Neuraxial labor analgesia, including epidural analgesia and combined spinal-epidural analgesia, is a well-established technique to alleviate labor pain. It can help to reduce the maternal stress response during labor and might be associated with a lower risk of maternal postpartum depression; which may be beneficial to the long-term neurodevelopment in offspring.

On the other hand, neuraxial labor analgesia is associated with increased risks of intrapartum maternal fever and instrumental delivery, which may produce potentially harmful effects. In addition, it has been reported that the anesthetic exposure during neuraxial analgesia may lead to fetal-neonatal depression and even neurotoxic effects of less mature neonatal brain. Taking all these into account, the potential long-term effects of neuraxial analgesia on offspring neurodevelopment is still controversial and deserves further study.

The objective of study is to investigate if there is any association between maternal neuraxial analgesia exposure during labor and risk of offspring neurodevelopment delay at age 24 months.

02

Conditions studied

  • Pregnant Women
  • Labor Pain
  • Analgesia, Epidural
  • Infants
  • Neurodevelopmental Disorders

Keywords

  • Pregnant women
  • Labor pain
  • Neuraxial labour analgesia
  • Infants
  • Neurodevelopmental disorders
03

In context

Labor Pain

423 studies on the registry are indexed under Labor Pain; 74 are open to participants now.

This study's planned enrollment of 4,645 is above the median of 132 across 62 observational studies indexed under Labor Pain.

Browse Labor Pain studies →

Lead sponsor

Dong-Xin Wang is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Primiparae between 18 and 35 years of age with term single cephalic pregnancy who undergo regular prenatal examination in the study centers and are preparing to deliver vaginally.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Primiparae between 18 and 35 years of age with term single cephalic pregnancy;
  2. Undergo regular prenatal examination in the study centers;
  3. Preparing to deliver vaginally.

Exclusion criteria

Exclusion Criteria:

  1. History of psychiatric diseases (indicate those that are diagnosed before or during pregnancy by psychiatrists);
  2. History of diseases involving the hypothalamic-pituitary-adrenal axis;
  3. Presence of to epidural analgesia, which includes: (1) History of infectious disease of the central nervous system (poliomyelitis, cerebrospinal meningitis, encephalitis, etc.); (2) History of spinal or intra-spinal disease (trauma or surgery of spinal column, intra-spinal canal mass, etc.); (3) Systemic infection (sepsis); (4) Skin or soft tissue infection at the site of epidural puncture; (5) Coagulopathy.
  4. Presence of contraindications to vaginal delivery;
  5. Other reasons that are considered unsuitable for study participation.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
4,645 participants (estimated)
Target follow-up
24 Months
Patient registry
Yes

Groups and cohorts

  • Neuraxial analgesia exposure

    For mothers who accept neuraxial labor analgesia, epidural analgesia or combined spinal-epidural analgesia will be provided according to routine practice of each study center.

    Procedure: Neuraxial labor analgesia

  • No neuraxial analgesia exposure

    For patients who do not accept neuraxial labor analgesia, analgesics will be prescribed by obstetricians according to routine practice.

    Procedure: No neuraxial labor analgesia

Interventions

  • ProcedureNeuraxial labor analgesia

    Epidural or combined spinal-epidural labor analgesia will be performed according to the routine practice of each study center.

  • ProcedureNo neuraxial labor analgesia

    Neuraxial analgesia will not be performed. Analgesics will be prescribed by the obstetricians according to routine practice.

06

What researchers measure

Primary outcomes

  1. Prevalence of neurodevelopmental delay in offspring at 24 months of age

    Neurodevelopment will be assessed using the Ages \& Stages Questionnaires® in Chinese, 3rd edition (ASQ®-3 Chinese; suitable for children from 1 month to 60 months of age). The ASQ®-3 Chinese contains 30 items representing five developmental domains: communication, gross motor, fine motor, problem solving, and personal-social behavior. For each domain, a score that is more than 2 standard deviations below the mean indicates suspected neurodevelopmental delay. A score below the threshold in any of the 5 domains indicates suspected neurodevelopmental delay.

    Time frame: At 24 months of age

Secondary outcomes

  1. Prevalence of neurodevelopmental delay in offspring at 6 and 12 months of age

    Neurodevelopment will be assessed using the Ages \& Stages Questionnaires® in Chinese, 3rd edition (ASQ®-3 Chinese; suitable for children from 1 month to 60 months of age). The ASQ®-3 Chinese contains 30 items representing five developmental domains: communication, gross motor, fine motor, problem solving, and personal-social behavior. For each domain, a score that is more than 2 standard deviations below the mean indicates suspected developmental delay. A score below the threshold in any of the 5 domains indicates suspected developmental delay.

    Time frame: At 6 and 12 months of age

  2. Prevalence of maternal depressive symptoms

    Maternal depression will be assessed with the Edinburgh Postnatal Depression Scale (EPDS; scores range from 0 to 30, with higher scores inddicating more severe depressive symptoms). A EPDS score of 10 or higher is defined the presence of depressive symptoms.

    Time frame: At 42 days, 6 months, 12 months, and 24 months after childbirth

07

Study locations

2 of 2 sites recruiting
08

References and documents

Publications

  • Liu ZH, He ST, Deng CM, Ding T, Xu MJ, Wang L, Li XY, Wang DX. Neuraxial labour analgesia is associated with a reduced risk of maternal depression at 2 years after childbirth: A multicentre, prospective, longitudinal study. Eur J Anaesthesiol. 2019 Oct;36(10):745-754. doi: 10.1097/EJA.0000000000001058. PubMed 31356375 ↗
  • Wong CA. Advances in labor analgesia. Int J Womens Health. 2010 Aug 9;1:139-54. doi: 10.2147/ijwh.s4553. PubMed 21072284 ↗
  • Morton S, Kua J, Mullington CJ. Epidural analgesia, intrapartum hyperthermia, and neonatal brain injury: a systematic review and meta-analysis. Br J Anaesth. 2021 Feb;126(2):500-515. doi: 10.1016/j.bja.2020.09.046. Epub 2020 Nov 18. PubMed 33218673 ↗
  • Flick RP, Lee K, Hofer RE, Beinborn CW, Hambel EM, Klein MK, Gunn PW, Wilder RT, Katusic SK, Schroeder DR, Warner DO, Sprung J. Neuraxial labor analgesia for vaginal delivery and its effects on childhood learning disabilities. Anesth Analg. 2011 Jun;112(6):1424-31. doi: 10.1213/ANE.0b013e3181f2ecdd. Epub 2010 Aug 24. PubMed 20736436 ↗
  • Wall-Wieler E, Bateman BT, Hanlon-Dearman A, Roos LL, Butwick AJ. Association of Epidural Labor Analgesia With Offspring Risk of Autism Spectrum Disorders. JAMA Pediatr. 2021 Jul 1;175(7):698-705. doi: 10.1001/jamapediatrics.2021.0376. PubMed 33871547 ↗
  • Wei M, Bian X, Squires J, Yao G, Wang X, Xie H, Song W, Lu J, Zhu C, Yue H, Zhu G, Wang Q, Xu R, Wan C, Sun S, Chen J. [Studies of the norm and psychometrical properties of the ages and stages questionnaires, third edition, with a Chinese national sample]. Zhonghua Er Ke Za Zhi. 2015 Dec;53(12):913-8. Chinese. PubMed 26887546 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04964206
Lead sponsor
Dong-Xin Wang
Collaborators
Shenzhen Maternity & Child Healthcare Hospital
Responsible party
Dong-Xin Wang (Professor and Chairman, Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital) — Sponsor-investigator
First posted
Jul 16, 2021
Start date
Oct 14, 2022
Primary completion
Dec 2026 (estimated)
Completion
Dec 2028 (estimated)
Last update
Jun 9, 2026

Study contacts

Dong-Xin Wang, MD,PHD
Contact
wangdongxin@hotmail.com
86-13910731903
Ting Ding, MD
Contact
athenading01@hotmail.com
86-13718803529
Dong-Xin Wang, MD,PHD
principal investigator · Peking University First Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion